Where are the main export markets for Reyoung Pharma products?

Products are exported to over 70 countries, covering Asia, South America, Africa, CIS Countries, the Middle East, and Europe, including Thailand, Philippines, Colombia, Peru, Germany, and Russia.

What is the physical state and shape of Cefazolin Sodium for Injection?

The product is in a solid state and has a powder shape.

Who is Reyoung Pharmaceutical Co., Ltd.?

Established in 1966, Reyoung Pharma is a leading manufacturer and distributor of pharmaceutical products in China, with over 5000 staff and three main factories covering 1,000,000 square meters.

Cephalosporin Antibacterial Cefazolin Sodium for Injection

Name: Cephalosporin Antibacterial Cefazolin Sodium for Injection
Brand: Reyoung Pharmaceutical Co., Ltd.
SKU: 787639332

Shandong, ChinaReyoung Pharmaceutical Co., Ltd.

US$0.22

100,000 vial

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

for Injection

Model NO.

0.5g, 1.0g

Suitable for

Elderly, Children, Adult

State

Solid

Shape

Powder

Type

Organic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

Lu20160062

Drug Ad Approval No.

Lu20160062

Certificate

GMP, SGS, ISO

Transport Package

10vials/Tray/Box, 50vials/Tray/Box.

Specification

0.25g, 0.5g, 1.0g

Trademark

Reyoung

Origin

China Reyoung

HS Code

3003909090

Production Capacity

5million Vials/Year

Key features

Broad Clinical Application: Treats respiratory, urinary, skin, bone infections, septicemia, and serves as surgical prophylaxis.

Massive Production Capacity: Annual output reaches 2.5 billion vials of powder for injection and 2000 tons of API.

Global Market Presence: Exported to over 70 countries across Asia, South America, Africa, CIS, Middle East, and Europe.

Strict Quality Certifications: Certified with GMP, ISO9001, ISO14001, and passed inspections in Colombia, Peru, and more.

Established Manufacturer: Leading Chinese pharmaceutical manufacturer established in 1966 with 1.5 billion USD assets.

OEM/ODM Services: Provides OEM and ODM services with 370 R&D engineers supporting product development.

Diverse Product Portfolio: Produces 400+ specifications including tablets, capsules, granules, and sterile active ingredients.

Advanced Production Facilities: Three main factories covering 1,000,000 square meters with automated lyophilization and robotics.

Company profile

Reyoung Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The available information identifies it as a pharmaceutical manufacturer supplying injectable antibiotics, oral solid medicines, veterinary cefotaxime sodium sterile, and lyophilized products. It reports more than 10 production lines, 370 years of combined R&D engineer experience, 50 quality-control staff, and ISO9001, ISO14001, and ISO45001 certifications. Export sales represent 31%–40% of total sales, with exporting reported since 2020 in one record and since 1998 in the company description, creating a discrepancy. Trade records show limited documented transactions and associated buyers in Bolivia, India, and Vietnam. Evidence is insufficient to assess after-sales service, financial credibility, customization, or verified customer performance comprehensively.

Supplier typeThe supplier is identified as a limited company and pharmaceutical manufacturer based in Shandong, China. Its stated products include injectable cephalosporins and penicillins, oral solid medicines, lyophilized products, and veterinary medicines, indicating a combined manufacturing and commercial business profile.

CertificationsThe supplier reports ISO9001:2015, ISO14001:2015, and ISO45001:2016 management-system certificates, along with cGMP, PIC/S, and ANVISA GMP holdings. These claims directly support established quality, environmental, occupational-safety, and pharmaceutical GMP capability, although certificate validity and scope are not independently shown.

R&D capabilityThe supplier reports 370 years of total R&D engineer experience and offers multiple dosage forms and pharmaceutical categories, including lyophilized products and injectable antibiotics. These details support R&D resources and product-development breadth, but no information confirms proprietary technologies, new product launches, patents, or development outcomes.

Production capacityProduction capability is supported by 4,950 employees, more than 10 production lines, pharmaceutical manufacturing descriptions, and product records for injectable antibiotics and veterinary cefotaxime sodium sterile. The plant-area entry is recorded as 0.0m², which is unusable or inconsistent data, so facility scale cannot be confirmed from that field.

Client casesTrade-related records associate the supplier with buyers in Bolivia, India, and Vietnam and show documented transactions for oral rehydration products, cefotaxime acid, and ceftriaxone sodium for injection. The records show some international commercial activity, but the number of stated transactions is limited and no customer testimonials, repeat-order evidence, or performance evaluations are provided.

Product Q&A

Q:What are the main indications for Cefazolin Sodium for Injection?

It is used to treat infections caused by sensitive bacteria, including otitis media, bronchitis, pneumonia, urinary tract infections, skin and soft tissue infections, bone and joint infections, septicemia, infectious endocarditis, and hepatobiliary system infections. It is also used as preventive medicine before surgery.

Q:What is the annual production capacity of Reyoung Pharma?

The annual production capacity includes 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, 4 billion tablets, 6 billion capsules, 200 million bags of granules, and 2000 tons of API.

Q:Which international certifications has Reyoung Pharma obtained?

Reyoung Pharma is certified with GMP, ISO9001, and ISO14001. It has also passed GMP inspections in countries such as Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d'Ivoire, Pakistan, Ukraine, Philippines, and Cambodia.

Q:Does Reyoung Pharma offer OEM or ODM services?

Yes, Reyoung Pharma offers both OEM and ODM services, supported by a team of 370 R&D engineers.

Q:What are the terms of payment and lead times?

Terms of payment include LC, T/T, and D/P. The average lead time is 1-3 months for both peak season and off-season.